A carregar...

Targeted intestinal delivery of incretin secretagogues—towards new diabetes and obesity therapies

A new strategy under development for the treatment of type 2 diabetes and obesity is to mimic some of the effects of bariatric surgery by delivering food-related stimuli to the distal gastrointestinal tract where they should enhance the release of gut hormones such as glucagon-like peptide-1 (GLP-1)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Peptides
Main Authors: Gribble, Fiona M., Meek, Claire L., Reimann, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science Inc 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805852/
https://ncbi.nlm.nih.gov/pubmed/29412834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.peptides.2017.11.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!